| MolecularWeight: | 406.42 |
| Formula: | C20H17F3N2O2S |
| Purity: | ≥98% |
| CAS#: | 1371569-69-5 |
| Solubility: | DMSOupto100mM |
| ChemicalName: | 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine |
| Storage: | Powder:4oC1year.DMSO:4oC3month;-20oC1year. |
BIOLOGicalActivity:
BETPispositiveallostericmodulatorandpartialagoNISToftheglucagon-likepeptide1(GLP-1)receptor.Itcovalentlymodifiescysteines347and438inGLP-1R.SpecificitystudieshaveshownthatithasnoactivityonGLP-2,GIP,PTHorglucagonreceptors.BETPhasbeenshowntopotentiateGLP-1R–dependentintracellularcalciummobilizationbutnotcAMPaccumulationinresponsetoGLP-1(7-36)NH2inrecombinantcelllines.Conversely,BETPcanenhancecAMPefficacyofGLP-1(9-36)NH2atGLP-1Rbutnotintracellularcalciummobilization.BETPalsopotentiatescAMPproductionofthedual-actingGLP-1R/glucagon(GCG)receptor(GCGR)agonistoxyntomodulinatGLP-1R.ItpromotesGLP-1(9-36)NH2–mediatedglucose-dependentinsulinsecretioninrodentandhumanisletpreparationsaswellasinrodentmodelsfollowingintravenousadministration.
HowtoUse:
Invitro:BETPwasusedat5-20µMinvitroandcellularassays.
Invivo:BETPwasadministeredthroughintravenousadministrationat5mg/kgtoWistarratsforIVGTT(InVivoIntravenousGlucoseToleranceTest).Formulation:10%ethanol-Solutol,20%polyethyleneglycol-400,and70%phosphate-bufferedsaline,pH7.4.
Reference:
- 1.SloopKW,etal.Novelsmallmoleculeglucagon-likepeptide-1receptoragoniststimulatesinsulinsecretioninrodentsandfromhumanislets.(2010)Diabetes.59(12):3099-107.
- 2.CheongYH,etal.Twosmallmoleculeagonistsofglucagon-likepeptide-1receptormodulatethereceptoractivationresponsedifferently.(2012)BiochemBiophysResCommun.417(1):558-63.
- 3.WillardFS,etal.Smallmoleculeallostericmodulationoftheglucagon-likePeptide-1receptorenhancestheinsulinotropiceffectofoxyntomodulin.(2012)MolPharmacol.82(6):1066-73.
- 4.NolteWM,etal.ApotentiatoroforthostericligandactivityatGLP-1Ractsviacovalentmodification.(2014)NatChemBiol.Inpress.
BETP_spec.pdf
BETP_MSDS.pdf
Productsareforresearchuseonly.Notforhumanuse
Xcess Biosciences，Inc.（XcessBio）由一群来自学术界和制药/生物技术行业的顶尖科学家于2008年成立，他们在药物化学，生物化学，分子和细胞生物学领域拥有丰富的专业知识。结合我们的合作者和顾问网络，我们致力于开发高质量的产品并提供最佳的服务，以满足生物医学研究中未满足的需求。
XcessBio的总部位于加利福尼亚州圣地亚哥，在最先进的研发设施中运营，设有化学合成实验室，分子和细胞生物学实验室以及分析质量控制实验室。
XcessBio一直为美国许多顶级制药，生物技术和试剂公司提供CRO服务和OEM产品，现在，我们将最好的产品和服务直接扩展到整个生命科学界。
暂无问答
本网站将在规定时间内给予删除等相关处理。
